TickerKhojComparison · NSE · data 2026-11-03
Hikal Limited vs Ind-Swift Laboratories Ltd.
In plain words
Size: Ind-Swift Laboratories Ltd. is about 1.1 times the market value of Hikal Limited.
Return on equity: Ind-Swift Laboratories Ltd. 3.4% vs Hikal Limited -4%.
Debt to equity: Hikal Limited 0.57 vs Ind-Swift Laboratories Ltd. 0.01.
Differences in the numbers, not a recommendation of either stock.
Side by side
19 metrics shown
| HIKAL | INDSWFTLAB | |
|---|---|---|
| Price | ₹214.53 | ₹343.75 |
| Market cap | ₹2,721 cr | ₹3,080 cr |
| P/E | — | 35.6 |
| P/B | — | 2 |
| ROE | -4.0% | 3.4% |
| ROCE | 3.1% | -0.2% |
| Debt / equity | 0.57 | 0.01 |
| Operating margin | 3.8% | 9.4% |
| Dividend yield | 0.27% | 0.00% |
| Sales growth, 3 years (yearly) | -5.4% | -19.6% |
| Profit growth, 3 years (yearly) | — | -3.2% |
| 1-year return | -10.2% | 234.7% |
| Revenue, last 12 months | ₹1,735 cr | ₹753 cr |
| Net profit, last 12 months | ₹-34 cr | ₹84 cr |
| Latest quarter | Sept 2026 | Sept 2026 |
| Quarter net profit | ₹-6 cr | ₹34 cr |
| Quarter profit vs a year earlier | — | +328.3% |
| Promoter holding | 68.85% | 42.93% |
| Health check | Weak (1.1/10) | Average (5.7/10) |
Common questions
Which earns a higher return on equity?
Ind-Swift Laboratories Ltd. (3.4% against -4.0%).
Which carries more debt?
Hikal Limited has the higher debt-to-equity ratio (0.57 against 0.01).